Rationale and design of the CANARI study: a case–control study investigating the association between prostate cancer and 5‐alpha‐reductase inhibitors for symptomatic benign prostate hypertrophy by linking SNIIRAM and pathology laboratories in a specific region in France

    loading  Checking for direct PDF access through Ovid


Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles